Transfusion reactions: prevention, diagnosis, and treatment
2016 · The Lancet · 469 citations
https://doi.org/10.1016/s0140-6736(15)01313-6
J
Joan Cid
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
378
Papers
6.3K
Citations
41
h-index
133
i10-index
Joan Cid is an academic researcher from Sociedad Española de Trombosis y Hemostasia. The author has contributed to research in topics: Blood transfusion and management & Blood groups and transfusion & Multiple Myeloma Research and Treatments. The author has an h-index of 41, co-authored 322 publications.
ORCID: 0000-0001-5445-4508Papers by this author
worksRituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
2018 · BMC Nephrology · 40 citations
https://doi.org/10.1186/s12882-018-1057-4
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
2022 · Cancer Immunology Immunotherapy · 31 citations
https://doi.org/10.1007/s00262-022-03283-5
Should DEHP be eliminated in blood bags?
2013 · Vox Sanguinis · 24 citations
https://doi.org/10.1111/vox.12099
Recommendations for living donor kidney transplantation
2022 · Nefrología (English Edition) · 16 citations
https://doi.org/10.1016/j.nefroe.2022.07.001
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
2022 · Molecular Therapy — Methods & Clinical Development · 12 citations
https://doi.org/10.1016/j.omtm.2022.06.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat